51 related articles for article (PubMed ID: 8365195)
1. Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers.
Cheng TY; Goodman GE; Thornquist MD; Barnett MJ; Beresford SA; LaCroix AZ; Zheng Y; Neuhouser ML
Int J Cancer; 2014 Nov; 135(9):2135-45. PubMed ID: 24622914
[TBL] [Abstract][Full Text] [Related]
2. Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers.
Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
Cancer Prev Res (Phila); 2018 Nov; 11(11):727-734. PubMed ID: 30254071
[TBL] [Abstract][Full Text] [Related]
3. Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis.
Fritz H; Kennedy D; Fergusson D; Fernandes R; Doucette S; Cooley K; Seely A; Sagar S; Wong R; Seely D
PLoS One; 2011; 6(6):e21107. PubMed ID: 21738614
[TBL] [Abstract][Full Text] [Related]
4. Conditional concordance-assisted learning under matched case-control design for combining biomarkers for population screening.
Li W; Li R; Yan Q; Feng Z; Ning J
Stat Med; 2023 Apr; 42(9):1398-1411. PubMed ID: 36733187
[TBL] [Abstract][Full Text] [Related]
5. Drugs for preventing lung cancer in healthy people.
Cortés-Jofré M; Rueda JR; Asenjo-Lobos C; Madrid E; Bonfill Cosp X
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD002141. PubMed ID: 32130738
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial.
Bonn SE; Barnett MJ; Thornquist M; Goodman G; Neuhouser ML
Eur J Cancer Prev; 2019 May; 28(3):212-219. PubMed ID: 29521683
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and lung cancer risk: a pooled analysis based on nested case-control studies from four cohort studies.
Sanikini H; Yuan JM; Butler LM; Koh WP; Gao YT; Steffen A; Johansson M; Vineis P; Goodman GE; Barnett MJ; Hung RJ; Chen C; Stücker I
BMC Cancer; 2018 Feb; 18(1):220. PubMed ID: 29471809
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
Wolpin BM; Rizzato C; Kraft P; Kooperberg C; Petersen GM; Wang Z; Arslan AA; Beane-Freeman L; Bracci PM; Buring J; Canzian F; Duell EJ; Gallinger S; Giles GG; Goodman GE; Goodman PJ; Jacobs EJ; Kamineni A; Klein AP; Kolonel LN; Kulke MH; Li D; Malats N; Olson SH; Risch HA; Sesso HD; Visvanathan K; White E; Zheng W; Abnet CC; Albanes D; Andreotti G; Austin MA; Barfield R; Basso D; Berndt SI; Boutron-Ruault MC; Brotzman M; Büchler MW; Bueno-de-Mesquita HB; Bugert P; Burdette L; Campa D; Caporaso NE; Capurso G; Chung C; Cotterchio M; Costello E; Elena J; Funel N; Gaziano JM; Giese NA; Giovannucci EL; Goggins M; Gorman MJ; Gross M; Haiman CA; Hassan M; Helzlsouer KJ; Henderson BE; Holly EA; Hu N; Hunter DJ; Innocenti F; Jenab M; Kaaks R; Key TJ; Khaw KT; Klein EA; Kogevinas M; Krogh V; Kupcinskas J; Kurtz RC; LaCroix A; Landi MT; Landi S; Le Marchand L; Mambrini A; Mannisto S; Milne RL; Nakamura Y; Oberg AL; Owzar K; Patel AV; Peeters PH; Peters U; Pezzilli R; Piepoli A; Porta M; Real FX; Riboli E; Rothman N; Scarpa A; Shu XO; Silverman DT; Soucek P; Sund M; Talar-Wojnarowska R; Taylor PR; Theodoropoulos GE; Thornquist M; Tjønneland A; Tobias GS; Trichopoulos D; Vodicka P; Wactawski-Wende J; Wentzensen N; Wu C; Yu H; Yu K; Zeleniuch-Jacquotte A; Hoover R; Hartge P; Fuchs C; Chanock SJ; Stolzenberg-Solomon RS; Amundadottir LT
Nat Genet; 2014 Sep; 46(9):994-1000. PubMed ID: 25086665
[TBL] [Abstract][Full Text] [Related]
9. Anti-HE4 antibodies in infertile women and women with ovarian cancer.
Hellstrom I; Swisher E; Hellstrom KE; Yip YY; Agnew K; Luborsky JL
Gynecol Oncol; 2013 Sep; 130(3):629-33. PubMed ID: 23727327
[TBL] [Abstract][Full Text] [Related]
10. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.
Brenner DR; Brennan P; Boffetta P; Amos CI; Spitz MR; Chen C; Goodman G; Heinrich J; Bickeböller H; Rosenberger A; Risch A; Muley T; McLaughlin JR; Benhamou S; Bouchardy C; Lewinger JP; Witte JS; Chen G; Bull S; Hung RJ
Hum Genet; 2013 May; 132(5):579-89. PubMed ID: 23370545
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
Bjelakovic G; Nikolova D; Gluud LL; Simonetti RG; Gluud C
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD007176. PubMed ID: 22419320
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers.
Sakoda LC; Loomis MM; Doherty JA; Neuhouser ML; Barnett MJ; Thornquist MD; Weiss NS; Goodman GE; Chen C
Cancer Causes Control; 2011 Mar; 22(3):449-61. PubMed ID: 21229299
[TBL] [Abstract][Full Text] [Related]
13. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.
Anderson GL; McIntosh M; Wu L; Barnett M; Goodman G; Thorpe JD; Bergan L; Thornquist MD; Scholler N; Kim N; O'Briant K; Drescher C; Urban N
J Natl Cancer Inst; 2010 Jan; 102(1):26-38. PubMed ID: 20042715
[TBL] [Abstract][Full Text] [Related]
14. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial.
Neuhouser ML; Barnett MJ; Kristal AR; Ambrosone CB; King IB; Thornquist M; Goodman GG
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2202-6. PubMed ID: 19661078
[TBL] [Abstract][Full Text] [Related]
15. Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers.
Littman AJ; Jackson LA; White E; Thornquist MD; Gaydos CA; Vaughan TL
Clin Diagn Lab Immunol; 2004 May; 11(3):615-7. PubMed ID: 15138190
[TBL] [Abstract][Full Text] [Related]
16. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET).
Thornquist MD; Omenn GS; Goodman GE; Grizzle JE; Rosenstock L; Barnhart S; Anderson GL; Hammar S; Balmes J; Cherniack M
Control Clin Trials; 1993 Aug; 14(4):308-24. PubMed ID: 8365195
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
[TBL] [Abstract][Full Text] [Related]
18. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
[TBL] [Abstract][Full Text] [Related]
19. Carotene and retinol efficacy trial: lung cancer chemoprevention trial in heavy cigarette smokers and asbestos-exposed workers. CARET Coinvestigators and Staff.
Goodman GE; Omenn GS
Adv Exp Med Biol; 1992; 320():137-40. PubMed ID: 1442278
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
